Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Appointing Candidates for Directors, Auditor, and Alternate Audit & Supervisory Board Member
Financial Results - Fiscal Year Ended December 31, 2025
Company Presentation
Summary of Non-consolidated Financial Results for the Fiscal Year ended December 31, 2025 [Under Japanese GAAP]
SpiroChem and Veritas In Silico Sign MoU to Accelerate Discovery of Next Generation RNA Binding Chemical Matter
The Jikei University School of Medicine and Veritas In Silico announce Patent Publication for Novel Nucleic Acid Therapeutic Targeting ALS
Upgrading the Drug Discovery Platform ibVIS to aibVIS
Patent Application for the mRNA-Targeted Nucleic Acid Drugs in the In-house Pipeline
Company Presentation
Completion of Patent Examination and Patent Grant Procedures for Drug Delivery System "Perfusio"
Start of Joint Research Project with Shimane University Aimed at Developing a Novel Drugs to Suppress Post-Lung Transplant Dysfunction
Organizational Reforms and Personnel Changes
[Summary] Financial Results for the Nine Months
Financial Results - Fiscal Year Ending December 2025, 3rd Quarter
Non-consolidated Financial Results for the Nine Months Ended September 30, 2025 [Under Japanese GAAP]
Dexerials Corporation and Veritas In Silico announce Start of Joint Technology Development for Establishing High-Speed and High-Accurate Spectroscopic
Revised Financial Forecast for FY2025
Relocation of the Shin-Kawasaki Research Institute
The Jikei University School of Medicine and VIS announce Start of Joint Research for Fundamentally Enhancing Therapeutic Effects of Pharmaceuticals
Nomination of a Candidate for Independent Outside Director